3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
2
Recruiting
2
Completed
2
Withdrawn
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Diffuse Intrinsic Pontine Glioma
1
Brain Stem Neoplasms
1
Brain Neoplasms
1
Interventions
Temozolomide
20
Magnetic Resonance Spectroscopy
10
Radiotherapy
9
Blood Specimen Collection
8
pembrolizumab
6
Cyclophosphamide
6
Bevacizumab
6
AZD 6244
6
Radiation
5
Specimen Handling
4
vorasidenib
3
fludarabine
3
cemiplimab
3
aflutinib
3
Surgical Procedures, Operative
3
Saline Solution
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Pemetrexed
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
tislelizumab
2
osimertinib
2
naxitamab
2
gallium maltolate
2
fludarabine phosphate
2
dinutuximab
2
Topotecan
2
Standard of Care
2
Spinal Puncture
2
Receptors, Interleukin-8B
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Re-Irradiation
×
CNS
×
Clear all
NCT06093165
2023-10-23
REMIT
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
59 enrolled